REVB Q2 2022 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,262

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-2043.55

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$90,188

Balance Sheet

Total Assets

$4M

Total Liabilities

$6M

Stockholders' Equity

-$2M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,262	-$14,703	+57.4%
Operating Income	-$2M	-$2M	+23.8%
Net Income	-$2M	-$2M	+25.7%